[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"University of Wuerzburg\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":89},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,3,0,[8,42,64],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":31,"startDateStruct":34,"completionDateStruct":36,"leadSponsor":38,"locationsCount":41},"100107943","adrenal-tumors---pathogenesis-and-therapy-100107943",false,"NCT00669266","Adrenal Tumors - Pathogenesis and Therapy","Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen","Inclusion Criteria:\n\n* adrenal tumor detected by imaging\n\nExclusion Criteria:","ALL","100 Years",{"count":19,"type":20},500,"ESTIMATED","OBSERVATIONAL","The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options for malignant tumors are poor. The current study investigates different aspects of the pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with adrenocortical carcinoma.",[24,25,26,27,28],"Adrenal Tumors","Adrenocortical Carcinoma","Cushing Syndrome","Conn Syndrome","Pheochromocytoma","RECRUITING","2026-05-01",{"date":32,"type":33},"2026-05-07","ACTUAL",{"date":35,"type":33},"2002-09",{"date":37,"type":20},"2032-12",{"name":39,"class":40},"University of Wuerzburg","OTHER",1,{"id":43,"slug":44,"hasResults":11,"nctId":45,"briefTitle":46,"officialTitle":47,"acronym":4,"eligibilityCriteria":48,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":49,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":51,"conditions":52,"keywords":53,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":30,"lastUpdatePostDateStruct":58,"startDateStruct":59,"completionDateStruct":61,"leadSponsor":63,"locationsCount":41},"100091717","german-adrenocortical-carcinoma-registry-100091717","NCT00453674","German Adrenocortical Carcinoma Registry","Deutsches Nebennieren-Karzinom-Register - German Adrenocortical Carcinoma Registry","Inclusion Criteria:\n\n* Histologically confirmed diagnosis of adrenocortical carcinoma",{"count":50,"type":20},1000,"Basic objective of the German Adrenocortical Carcinoma Registry is to improve the care of patients with adrenocortical cancer. The registration of as many patients as possible helps to collect data for the prognosis and prospects of success regarding different treatment plans. This data will be taken into consideration for planning prospective studies. With this registry, the recruitment of patients for prospective studies will be significantly facilitated. In this way - and in cooperation with networks in other countries (e.g. in Italy and France) - a structure allowing systematic improvement of therapy will be developed.",[25],[54,55,56,57],"Adrenal cancer","Treatment","Surgery","Mitotane",{"date":32,"type":33},{"date":60,"type":33},"2003-01",{"date":62,"type":20},"2030-12",{"name":39,"class":40},{"id":65,"slug":66,"hasResults":11,"nctId":67,"briefTitle":68,"officialTitle":69,"acronym":4,"eligibilityCriteria":70,"healthyVolunteers":11,"sex":16,"minAge":71,"maxAge":4,"enrollmentInfo":72,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":74,"conditions":75,"keywords":4,"overallStatus":29,"whyStopped":4,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":84,"completionDateStruct":86,"leadSponsor":88,"locationsCount":41},"100484250","registry-for-hypoparathyroidism-wuerzburg-100484250","NCT05585593","Registry for Hypoparathyroidism Wuerzburg","Registry and Biobank for Patients With Hypoparathyroidism Wuerzburg","Inclusion Criteria:\n\n* age of 18\n* chronic hypoparathyroidism (\\>12 months) under established therapy or chronic pseudohypoparathyroidism (\\>12 months) under established therapy\n* written informed consent\n\nExclusion Criteria:\n\n* age \\\u003C18 years\n* no detailed documentation of hypo- or pseudohypoparathyroidism","18 Years",{"count":73,"type":20},300,"Long-term conventional treatment of chronic hypoparathyroidism does not fully restore calcium homeostasis leading to increased morbidity, emergency events and reduced subjective health status. To further investigate general morbidity, hypocalcemic events, subjective and daily life performance in patients with chronic hypoparathyroidism a standardized interview as well as blood sampling and examinations such as echocardiography and renal ultrasound are performed.",[76,77,78,79,80],"Comorbidities and Coexisting Conditions","Morality","Hypocalcemia","Hypercalcemia","Quality of Life","2022-11-02",{"date":83,"type":33},"2022-11-08",{"date":85,"type":33},"2017-10-18",{"date":87,"type":20},"2032-01-01",{"name":39,"class":40},""]